Download PDF
1 / Pages

Other users also viewed these articles

Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis Liwei Zhuang; Junnan Li; Yu Zhang; Shibo Ji; Yue Li; Yingying Zhao; Ben Li; Wei Li; Min Quan; Ying Duan; Hong Zhao; Danying Cheng; Xiaomei Wang; Weini Ou; Huichun Xing;
10.1016/j.aohep.2020.09.012
Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;
10.1016/j.aohep.2024.101582
Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;
Ann Hepatol. 2023;28: